comparemela.com

DMK Pharmaceuticals Corporation (NASDAQ: DMK) shares are trading higher Thursday after the company announced that it has regained the full rights to commercialize Zimhi (naloxone) after the termination of an exclusive commercialization and

Related Keywords

Canada ,United States , ,Pharmaceuticals Corporation ,Us Worldmeds ,Benzinga Pro ,Going On With Canopy Growth ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.